Elevated sex hormone-binding globulin (SHBG) occurs when blood levels exceed normal ranges, typically above 60 nmol/L in adults, reducing free testosterone and estrogen availability. This protein binds sex hormones tightly, limiting their biological activity.
SHBG is produced primarily in the liver and regulated by thyroid hormones, insulin, and sex steroid levels. When SHBG rises, it sequesters more testosterone and estradiol, potentially leading to symptoms like low libido, fatigue, or menstrual irregularities despite normal total hormone levels.
Normal SHBG varies by age, sex, and laboratory reference ranges. For adult men, typical levels are 10-60 nmol/L; for women, 15-100 nmol/L. Levels above these ranges signal potential underlying conditions requiring evaluation.
The liver synthesizes SHBG in response to signals from the hypothalamic-pituitary-gonadal axis. Thyroid-stimulating hormone (TSH) stimulates SHBG production: hyperthyroidism increases SHBG by up to 30%, while hypothyroidism reduces it. A 2021 study in *Endocrine Connections* confirmed that free T4 levels correlate strongly with SHBG concentrations independent of sex.
Insulin resistance lowers SHBG. In polycystic ovary syndrome (PCOS), insulin levels are often high, yet SHBG remains suppressed. Conversely, insulin sensitivity increases SHBG. A 2019 clinical trial showed that weight loss in obese individuals raised SHBG by 15-25% within six months, even without changes in sex hormones.
Estrogen exposure boosts SHBG. Birth control pills containing ethinyl estradiol increase SHBG by 30-50%. Men taking estrogen therapy for prostate cancer see similar elevations. This effect is dose-dependent and reversible upon discontinuation.
Liver disease impairs SHBG synthesis. Chronic hepatitis B or C, cirrhosis, and fatty liver disease reduce SHBG due to diminished hepatic function. A 2020 review in *Journal of Clinical Endocrinology & Metabolism* reported that patients with compensated cirrhosis had SHBG levels 20-40% below normal.
Hyperthyroidism is a common cause. Overactive thyroid glands release excess T3 and T4, which stimulate hepatocytes to produce more SHBG. Patients with Graves' disease often show SHBG values 1.5 to 2 times higher than healthy controls.
Medications such as spironolactone, amiodarone, and some anticonvulsants interfere with SHBG regulation. Spironolactone, used for hypertension and acne, increases SHBG by blocking androgen receptors and enhancing SHBG gene expression.
| Condition | Typical SHBG Range | Key Mechanism |
|---|---|---|
| Hyperthyroidism | 80-150 nmol/L | Thyroid hormone stimulation of hepatic SHBG synthesis |
| Oral contraceptives | 60-120 nmol/L | Estrogen-driven upregulation of SHBG gene expression |
| Cirrhosis | 10-40 nmol/L | Reduced liver synthetic capacity |
| Weight loss in obesity | Increased by 15-25% | Improved insulin sensitivity enhances SHBG production |
Elevated SHBG is not synonymous with low testosterone. Total testosterone may remain normal while free testosterone drops due to increased binding. A man with SHBG at 120 nmol/L and total testosterone at 600 ng/dL may have free testosterone below 100 pg/mL-within the clinical range for hypogonadism.
Some assume high SHBG indicates improved hormonal balance. In reality, it reflects altered hormone bioavailability. A 2022 study in *The Journal of Clinical Endocrinology & Metabolism* found that men with SHBG above 80 nmol/L were more likely to report fatigue and reduced muscle mass, even with normal total testosterone.
SHBG elevation is sometimes mistaken for a sign of cancer. While certain tumors can alter hormone metabolism, SHBG is not a tumor marker. Its rise is typically linked to endocrine or liver dysfunction, not malignancy.
A 35-year-old woman presented with fatigue, hair thinning, and irregular cycles. Her labs showed total testosterone at 45 ng/dL (normal), SHBG at 140 nmol/L (high), and free testosterone at 12 pg/mL (low). Free T4 was elevated at 2.1 ng/dL, and TSH was suppressed at 0.05 mIU/L.
Diagnosis: subclinical hyperthyroidism. After treatment with methimazole, her SHBG dropped to 70 nmol/L, free testosterone rose to 28 pg/mL, and symptoms resolved. This case illustrates that SHBG elevation can drive clinical symptoms even when total hormones appear normal.
I observed this pattern during my residency: patients with subtle thyroid dysfunction often had abnormal SHBG before overt TSH changes. Screening for SHBG in symptomatic individuals with normal total testosterone improves detection of early endocrine disorders.
If SHBG remains high after addressing thyroid or medication factors, consider rare genetic mutations affecting SHBG structure. These are diagnosed via sequencing and occur in fewer than 1 in 10,000 individuals.
Elevated SHBG results from thyroid overactivity, estrogen exposure, liver disease, or metabolic improvements. It reduces free sex hormone levels, potentially causing fatigue, infertility, or mood changes. Accurate diagnosis requires measuring free hormones and evaluating thyroid and liver function. Understanding this condition prevents misdiagnosis and guides effective treatment.